Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.95
May. 30, 2025 16:00:01- Change -0.015 (-1.5544%)
- Volume 91,725
- Today's Open 0.96
- Previous Close 0.965
- Today's High 0.9903
- Today's Low 0.95
- 52 Week High 4.3
- 52 Week Low 0.95